HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
rifazone-82
structure
Also Known As:
R-8(2); rifazone-8(2)
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
4 or More Rings Heterocyclic Compounds
Rifamycins: 416
rifazone-82: 2
Polycyclic Compounds: 6
Macrocyclic Compounds: 15
Macrocyclic Lactams: 28
Rifamycins: 416
rifazone-82: 2
Related Diseases
1.
Neoplasms (Cancer)
01/01/1978 - "
A growth inhibitory effect on adenocarcinoma TA3 ascites tumors in LAF1/J mice resulted from the repeated IP administration of subtoxic doses of 3 rifamycin derivatives: rifampicin (Rif)1, dimethylbenzyldesmethylrifampicin (DMB), and rifazone-82 (R-82).
"
01/01/1979 - "
The cytotoxicity of 2 rifamycin derivatives, rifazone-82 and rifampicin, on mouse ascites cells was studied, using the [125I]iododeoxyuridine (IUDR) method of labeling the tumor cells.
"
2.
Ascites
01/01/1978 - "
A growth inhibitory effect on adenocarcinoma TA3 ascites tumors in LAF1/J mice resulted from the repeated IP administration of subtoxic doses of 3 rifamycin derivatives: rifampicin (Rif)1, dimethylbenzyldesmethylrifampicin (DMB), and rifazone-82 (R-82).
"
01/01/1979 - "
The cytotoxicity of 2 rifamycin derivatives, rifazone-82 and rifampicin, on mouse ascites cells was studied, using the [125I]iododeoxyuridine (IUDR) method of labeling the tumor cells.
"
3.
Adenocarcinoma
01/01/1978 - "
A growth inhibitory effect on adenocarcinoma TA3 ascites tumors in LAF1/J mice resulted from the repeated IP administration of subtoxic doses of 3 rifamycin derivatives: rifampicin (Rif)1, dimethylbenzyldesmethylrifampicin (DMB), and rifazone-82 (R-82).
"
Related Drugs and Biologics
1.
Rifamycins
2.
Rifampin (Rifampicin)
3.
Idoxuridine (Stoxil)